(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are AFFLUENT MEDICAL, POXEL, and ALUMEXX N.V..

Financial Asset	Price	Change	Updated (EST)
AFFLUENT MEDICAL (AFME.PA)	1.88	27.89%	2023-12-21 12:45:09
POXEL (POXEL.PA)	0.42	22.81%	2023-12-21 13:21:34
ALUMEXX N.V. (ALX.AS)	0.84	21.9%	2023-12-21 12:00:24
ZAPTEC (ZAP.OL)	21.92	11.72%	2023-12-21 12:44:32
ATLANTIC SAPPHIRE (ASA.OL)	1.92	11.64%	2023-12-21 12:24:44
GREENVOLT (GVOLT.LS)	8.15	9.4%	2023-12-21 12:23:18
BENEVOLENTAI (BAI.AS)	0.55	9%	2023-12-21 12:00:52
POLIGHT (PLT.OL)	20.50	8.58%	2023-12-21 12:42:17
FOUNTAIN (FOU.BR)	1.21	8.04%	2023-12-21 12:06:04
XILAM ANIMATION (XIL.PA)	3.98	7.86%	2023-12-21 13:24:55

The three biggest losers today are CASINO GUICHARD, ALMUNDA PRO NV, and METABOLIC EXPLORER.

Financial Asset	Price	Change	Updated (EST)
CASINO GUICHARD (CO.PA)	0.65	-7.41%	2023-12-21 13:00:54
ALMUNDA PRO NV (AMUND.AS)	1.17	-7.14%	2023-12-21 12:00:23
METABOLIC EXPLORER (METEX.PA)	0.32	-5.67%	2023-12-21 13:20:23
ARTEA (ARTE.PA)	14.20	-5.33%	2023-12-21 12:45:46
OCEANTEAM (OTS.OL)	1.25	-5.3%	2023-12-21 12:41:43
INVENTIVA (IVA.PA)	3.96	-5.04%	2023-12-21 13:05:10
NORTHERN OCEAN LTD (NOL.OL)	9.98	-4.95%	2023-12-21 12:41:34
ECONOCOM GROUP (ECONB.BR)	2.52	-4.55%	2023-12-21 12:05:48
VALNEVA (VLA.PA)	4.59	-4.42%	2023-12-21 13:24:15
MARTIFER (MAR.LS)	1.24	-4.26%	2023-12-21 12:23:30

Winners today

1. AFFLUENT MEDICAL (AFME.PA)

27.89% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL rising 27.89% to €1.88 on Thursday while CAC 40 fell 0.16% to €7,571.40.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.36%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 25.8%, now sitting on 1.34M for the twelve trailing months.

More news about AFFLUENT MEDICAL.

2. POXEL (POXEL.PA)

22.81% Price Change

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.

CAC 40 ended the session with POXEL jumping 22.81% to €0.42 on Thursday while CAC 40 dropped 0.16% to €7,571.40.

Earnings Per Share

As for profitability, POXEL has a trailing twelve months EPS of €-1.08.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1050.6%, now sitting on 1.55M for the twelve trailing months.

Volatility

POXEL’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.54%, a negative 0.28%, and a positive 2.62%.

POXEL’s highest amplitude of average volatility was 4.64% (last week), 2.17% (last month), and 2.62% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, POXEL’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

POXEL’s stock is valued at €0.42 at 21:40 EST, way under its 52-week high of €1.08 and way higher than its 52-week low of €0.30.

More news about POXEL.

3. ALUMEXX N.V. (ALX.AS)

21.9% Price Change

Alumexx N.V. manufactures and sells scaffoldings, stairs, ladders, accessories, and tools for indoor or outdoor use in the Netherlands and internationally. The company was formerly known as Phelix N.V. and changed its name to Alumexx N.V. in January 2018. Alumexx N.V. was founded in 1991 and is based in Etten-Leur, the Netherlands.

AEX-Index ended the session with ALUMEXX N.V. jumping 21.9% to €0.84 on Thursday, after three successive sessions in a row of losses. AEX-Index slid 0.48% to €789.88, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ALUMEXX N.V. has a trailing twelve months EPS of €0.12.

PE Ratio

ALUMEXX N.V. has a trailing twelve months price to earnings ratio of 6.96. Meaning, the purchaser of the share is investing €6.96 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.26%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALUMEXX N.V.’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for ALUMEXX N.V. is 82260 which is 2035.51% above its average volume of 3852.

More news about ALUMEXX N.V..

4. ZAPTEC (ZAP.OL)

11.72% Price Change

Zaptec ASA engages in the development and sale of chargers, charging systems, and services for electric car charging in Norway, Sweden, Switzerland, Denmark, Iceland, rest of Europe, and internationally. It offers Zaptec Go, a charging unit for use in homes, private garages, or parking spaces; Zaptec Pro, a charging station for parking spaces in housing cooperatives and co-ownership properties, companies, and newbuilds; charging stations for outdoor installations; Zaptec Park, an automatic payment solution; Zaptec Portal for monitoring, balancing, and optimizing the load between the various charging stations; and Zaptec Sense for automatically adjusting the charging speed in the buildings. The company was founded in 2012 and is based in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with ZAPTEC jumping 11.72% to €21.92 on Thursday while Oslo Børs Benchmark Index_GI dropped 0.34% to €1,292.59.

Earnings Per Share

As for profitability, ZAPTEC has a trailing twelve months EPS of kr0.02.

PE Ratio

ZAPTEC has a trailing twelve months price to earnings ratio of 1096. Meaning, the purchaser of the share is investing kr1096 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.15%.

Volatility

ZAPTEC’s last week, last month’s, and last quarter’s current intraday variation average was 2.46%, 0.29%, and 2.89%.

ZAPTEC’s highest amplitude of average volatility was 4.15% (last week), 2.89% (last month), and 2.89% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

ZAPTEC’s EBITDA is 1.05.

Volume

Today’s last reported volume for ZAPTEC is 2079990 which is 288.02% above its average volume of 536040.

More news about ZAPTEC.

5. ATLANTIC SAPPHIRE (ASA.OL)

11.64% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE rising 11.64% to €1.92 on Thursday while Oslo Børs Benchmark Index_GI fell 0.34% to €1,292.59.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-5.05.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about ATLANTIC SAPPHIRE.

6. GREENVOLT (GVOLT.LS)

9.4% Price Change

Greenvolt – Energias Renováveis, S.A. operates in the renewable energy sector in Portugal, the United Kingdom, and internationally. The company operates through Residual Biomass; Development of Wind and Solar Utility-Scale; and Distributed Generation segments. It is involved in operation and development of biomass plants, as well as development of wind and solar photovoltaic plants in the European markets. The company was formerly known as Bioelétrica da Foz, S.A. and changed its name to Greenvolt – Energias Renováveis, S.A. Greenvolt – Energias Renováveis, S.A. was incorporated in 2002 and is headquartered in Porto, Portugal.

PSI ended the session with GREENVOLT rising 9.4% to €8.15 on Thursday, after three consecutive sessions in a row of losses. PSI rose 0.69% to €6,388.46, after four successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, GREENVOLT has a trailing twelve months EPS of €0.03.

PE Ratio

GREENVOLT has a trailing twelve months price to earnings ratio of 271.67. Meaning, the purchaser of the share is investing €271.67 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.86%.

More news about GREENVOLT.

7. BENEVOLENTAI (BAI.AS)

9% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI jumping 9% to €0.55 on Thursday while AEX-Index fell 0.48% to €789.88.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.97%.

Yearly Top and Bottom Value

BENEVOLENTAI’s stock is valued at €0.55 at 21:40 EST, way under its 52-week high of €4.12 and way above its 52-week low of €0.49.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 11.01M for the twelve trailing months.

More news about BENEVOLENTAI.

8. POLIGHT (PLT.OL)

8.58% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; ASIC drivers, which control the supply of variable voltage to Tlens products and makes them to change focus; TLens Silver and TLens Silver Premium devices; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. it serves smartphones and wearables, barcode/industrial, augmented reality, medical endoscopy, webcams, and other markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT jumping 8.58% to €20.50 on Thursday while Oslo Børs Benchmark Index_GI fell 0.34% to €1,292.59.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.27%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 42.1%, now sitting on 21.46M for the twelve trailing months.

Moving Average

POLIGHT’s value is way higher than its 50-day moving average of kr13.12 and way above its 200-day moving average of kr13.28.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, POLIGHT’s stock is considered to be oversold (<=20).

Volatility

POLIGHT’s last week, last month’s, and last quarter’s current intraday variation average was 2.76%, 1.32%, and 2.69%.

POLIGHT’s highest amplitude of average volatility was 3.24% (last week), 3.30% (last month), and 2.69% (last quarter).

More news about POLIGHT.

9. FOUNTAIN (FOU.BR)

8.04% Price Change

Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in in France, Belgium, the Netherlands, and rest of European Countries. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was incorporated in 1972 and is based in Braine l'Alleud, Belgium.

BEL 20 ended the session with FOUNTAIN jumping 8.04% to €1.21 on Thursday, after three consecutive sessions in a row of losses. BEL 20 fell 0.91% to €3,619.66, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, FOUNTAIN has a trailing twelve months EPS of €-0.11.

Volume

Today’s last reported volume for FOUNTAIN is 19 which is 99.11% below its average volume of 2157.

More news about FOUNTAIN.

10. XILAM ANIMATION (XIL.PA)

7.86% Price Change

Xilam Animation operates as an audiovisual production company in France and internationally. The company creates, produces, and distributes original programs for children and adults. It also broadcasts content on television; subscription video on demand streaming platforms, including Netflix, Disney +, Amazon, and NBC Universal; and advertising video on demand streaming platforms, such as YouTube and Facebook. In addition, the company produces animated, series, mini-series, and feature films. It owns the Oggy, Cockroaches, Zig & Sharko, Chicky, Oggy Oggy in preschool, Oggy Next Gen, Les Tales of Lupin, Moka, Mr Magoo, Trico, and I Lost My Body brands. The company was incorporated in 1999 and is headquartered in Paris, France.

CAC 40 ended the session with XILAM ANIMATION rising 7.86% to €3.98 on Thursday, after five consecutive sessions in a row of losses. CAC 40 dropped 0.16% to €7,571.40, after two sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, XILAM ANIMATION has a trailing twelve months EPS of €0.08.

PE Ratio

XILAM ANIMATION has a trailing twelve months price to earnings ratio of 49.75. Meaning, the purchaser of the share is investing €49.75 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.96%.

More news about XILAM ANIMATION.

Losers Today

1. CASINO GUICHARD (CO.PA)

-7.41% Price Change

Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.Casino, Guichard-Perrachon S.A operates as a subsidiary of Rallye SA.

CAC 40 ended the session with CASINO GUICHARD dropping 7.41% to €0.65 on Thursday while CAC 40 fell 0.16% to €7,571.40.

Earnings Per Share

As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-20.53.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -65.71%.

Sales Growth

CASINO GUICHARD’s sales growth for the next quarter is negative 11.2%.

More news about CASINO GUICHARD.

2. ALMUNDA PRO NV (AMUND.AS)

-7.14% Price Change

Almunda Professionals N.V., a business and IT consultancy company, provides business services in the financial sector. It offers consultancy services in the areas of regulatory change, digital transformation, information security, and information services. The company was formerly known as Novisource N.V. and changed its name to Almunda Professionals N.V. in August 2021. Almunda Professionals N.V. was founded in 2001 and is based in Amsterdam, the Netherlands.

AEX-Index ended the session with ALMUNDA PRO NV falling 7.14% to €1.17 on Thursday while AEX-Index fell 0.48% to €789.88.

Earnings Per Share

As for profitability, ALMUNDA PRO NV has a trailing twelve months EPS of €-0.02.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.64%.

Moving Average

ALMUNDA PRO NV’s worth is under its 50-day moving average of €1.19 and under its 200-day moving average of €1.30.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jul 10, 2023, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 4.76%.

Yearly Top and Bottom Value

ALMUNDA PRO NV’s stock is valued at €1.17 at 21:40 EST, way below its 52-week high of €1.60 and above its 52-week low of €1.14.

More news about ALMUNDA PRO NV.

3. METABOLIC EXPLORER (METEX.PA)

-5.67% Price Change

METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.

CAC 40 ended the session with METABOLIC EXPLORER falling 5.67% to €0.32 on Thursday, after two consecutive sessions in a row of losses. CAC 40 slid 0.16% to €7,571.40, after two successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.

Moving Average

METABOLIC EXPLORER’s worth is way under its 50-day moving average of €0.40 and way under its 200-day moving average of €0.82.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, METABOLIC EXPLORER’s stock is considered to be overbought (>=80).

More news about METABOLIC EXPLORER.

4. ARTEA (ARTE.PA)

-5.33% Price Change

Artea SA operates as a real estate development company in France. It develops tertiary parks, emblematic projects, urban office buildings, eco-neighborhoods, hotels, shops, and housing projects. The company also generates and supplies electrical power using renewable sources, such as photovoltaics and hydraulics. Artea SA was founded in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with ARTEA dropping 5.33% to €14.20 on Thursday while CAC 40 slid 0.16% to €7,571.40.

Earnings Per Share

As for profitability, ARTEA has a trailing twelve months EPS of €-1.08.

Volatility

ARTEA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.02%, a negative 1.13%, and a positive 2.53%.

ARTEA’s highest amplitude of average volatility was 3.65% (last week), 1.49% (last month), and 2.53% (last quarter).

Volume

Today’s last reported volume for ARTEA is 309 which is 161.86% above its average volume of 118.

More news about ARTEA.

5. OCEANTEAM (OTS.OL)

-5.3% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM sliding 5.3% to €1.25 on Thursday while Oslo Børs Benchmark Index_GI fell 0.34% to €1,292.59.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.

Volume

Today’s last reported volume for OCEANTEAM is 44634 which is 68.97% above its average volume of 26414.

Moving Average

OCEANTEAM’s worth is way below its 50-day moving average of kr1.43 and way under its 200-day moving average of kr1.55.

Volatility

OCEANTEAM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.08%, a negative 0.50%, and a positive 4.89%.

OCEANTEAM’s highest amplitude of average volatility was 7.57% (last week), 5.38% (last month), and 4.89% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 33.3%, now sitting on 70k for the twelve trailing months.

More news about OCEANTEAM.

6. INVENTIVA (IVA.PA)

-5.04% Price Change

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

CAC 40 ended the session with INVENTIVA dropping 5.04% to €3.96 on Thursday while CAC 40 fell 0.16% to €7,571.40.

Earnings Per Share

As for profitability, INVENTIVA has a trailing twelve months EPS of €-1.9.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -258.06%.

Sales Growth

INVENTIVA’s sales growth for the next quarter is negative 15.4%.

Yearly Top and Bottom Value

INVENTIVA’s stock is valued at €3.96 at 21:40 EST, way under its 52-week high of €5.99 and way above its 52-week low of €1.88.

Volume

Today’s last reported volume for INVENTIVA is 56715 which is 22.75% above its average volume of 46201.

More news about INVENTIVA.

7. NORTHERN OCEAN LTD (NOL.OL)

-4.95% Price Change

Northern Ocean Ltd., a drilling contractor, provides offshore contract drilling services for the oil and gas industry worldwide. The company was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN OCEAN LTD sliding 4.95% to €9.98 on Thursday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 0.34% to €1,292.59, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, NORTHERN OCEAN LTD has a trailing twelve months EPS of kr-4.37.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.86%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 101.1% and 155.6%, respectively.

Volatility

NORTHERN OCEAN LTD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.85%, a negative 1.16%, and a positive 2.28%.

NORTHERN OCEAN LTD’s highest amplitude of average volatility was 3.12% (last week), 3.01% (last month), and 2.28% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 27777.1%, now sitting on 151.09M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORTHERN OCEAN LTD’s stock is considered to be oversold (<=20).

More news about NORTHERN OCEAN LTD.

8. ECONOCOM GROUP (ECONB.BR)

-4.55% Price Change

Econocom Group SE conceives, finances, and facilitates the digital transformation of large firms and public organizations. It offers financing solutions for the administrative and financial management of the ICT and digital assets of the businesses. The company provides consulting, infrastructure management, applications development, and digital solutions and systems integration, as well as design and roll-out solutions; and sells hardware and software, such as PCs, tablets, servers, printers, licences, digital objects, etc. It operates in 16 countries, including Europe, Morocco, Brazil, Mexico, Canada, and the United States. The company sells its products and services under the Econocom brand name. Econocom Group SE was incorporated in 1982 and is based in Puteaux, France.

BEL 20 ended the session with ECONOCOM GROUP falling 4.55% to €2.52 on Thursday, following the last session’s downward trend. BEL 20 fell 0.91% to €3,619.66, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, ECONOCOM GROUP has a trailing twelve months EPS of €0.29.

PE Ratio

ECONOCOM GROUP has a trailing twelve months price to earnings ratio of 8.67. Meaning, the purchaser of the share is investing €8.67 for every euro of annual earnings.

More news about ECONOCOM GROUP.

9. VALNEVA (VLA.PA)

-4.42% Price Change

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.

CAC 40 ended the session with VALNEVA dropping 4.42% to €4.59 on Thursday while CAC 40 slid 0.16% to €7,571.40.

Earnings Per Share

As for profitability, VALNEVA has a trailing twelve months EPS of €-0.82.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.81%.

Volume

Today’s last reported volume for VALNEVA is 409040 which is 11.58% above its average volume of 366580.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 119.7% and positive 259.4% for the next.

Sales Growth

VALNEVA’s sales growth is negative 76.3% for the present quarter and negative 58.9% for the next.

Yearly Top and Bottom Value

VALNEVA’s stock is valued at €4.59 at 21:40 EST, way below its 52-week high of €7.85 and way above its 52-week low of €3.95.

More news about VALNEVA.

10. MARTIFER (MAR.LS)

-4.26% Price Change

Martifer SGPS, S.A. operates in the metallic constructions and renewable energy development sectors worldwide. The company operates through Metallic Constructions, Naval Industry, and Renewables segments. The Metallic Constructions segment engages in the construction activities involving metal mechanical construction, aluminum, and glass façades, as well as infrastructures for oil and gas. The Naval Industry segment involved in shipbuilding, as well as provides ship repair services. The Renewables segment engages in the development of renewable energy projects, including wind and solar power projects. Martifer SGPS, S.A. was founded in 1990 and is headquartered in Oliveira de Frades, Portugal.

PSI ended the session with MARTIFER dropping 4.26% to €1.24 on Thursday while PSI rose 0.69% to €6,388.46.

Earnings Per Share

As for profitability, MARTIFER has a trailing twelve months EPS of €0.13.

PE Ratio

MARTIFER has a trailing twelve months price to earnings ratio of 9.5. Meaning, the purchaser of the share is investing €9.5 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.03%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 211.48M for the twelve trailing months.

Volume

Today’s last reported volume for MARTIFER is 14403 which is 53.43% above its average volume of 9387.

More news about MARTIFER.

Stay up to date with our winners and losers daily report